1
Clinical Trials associated with Haemophilus b conjugate vaccine(Royal (Wuxi) Bio-Pharmaceutical)进行III期临床试验,评价b型流感嗜血杆菌结合疫苗在2月龄~5周岁健康婴幼儿中接种的免疫原性和安全性
[Translation] Conduct a phase III clinical trial to evaluate the immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine in healthy infants aged 2 months to 5 years
评价罗益(无锡)生物制药有限公司研制的b型流感嗜血杆菌结合疫苗在中国2月龄~5周岁健康婴幼儿中接种的免疫原性和安全性。
[Translation] To evaluate the immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine developed by Luoyi (Wuxi) Biopharmaceutical Co., Ltd. in healthy infants aged 2 months to 5 years in China.
100 Clinical Results associated with Haemophilus b conjugate vaccine(Royal (Wuxi) Bio-Pharmaceutical)
100 Translational Medicine associated with Haemophilus b conjugate vaccine(Royal (Wuxi) Bio-Pharmaceutical)
100 Patents (Medical) associated with Haemophilus b conjugate vaccine(Royal (Wuxi) Bio-Pharmaceutical)
100 Deals associated with Haemophilus b conjugate vaccine(Royal (Wuxi) Bio-Pharmaceutical)